Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients
Author:
Affiliation:
1. Department of Urology; Oregon Health and Science University; Portland OR USA
2. Department of Pediatrics; Oregon Health and Science University; Portland OR USA
Publisher
Wiley
Subject
Transplantation,Pediatrics, Perinatology, and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.12159/fullpdf
Reference28 articles.
1. Complete steroid avoidance is effective and safe in children with renal transplants: A multicenter randomized trial with three-year follow-up;Sarwal;Am J Transplant,2012
2. Non-compliance and transfer from paediatric to adult transplant unit;Watson;Pediatr Nephrol,2000
3. Satisfaction and adherence with immunosuppressant treatment in renal transplant patients living with a working graft;Ortega;Study Group Satisfy. J Nephrol,2013
4. Adolescent transition to adult care in solid organ transplantation: A consensus conference report;Bell;Am J Transplant,2008
5. Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience;Tan;Transplantation,2008
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alemtuzumab induction is associated with decreased hospitalization rates in pediatric kidney transplant: A UNOS data review for safety and outcomes with common induction regimens;Pediatric Transplantation;2024-05-20
2. Induction Therapy in Pediatric Renal Transplant Recipients;Pediatric Solid Organ Transplantation;2023
3. Peculiarities of the induction immunosuppressive therapy in renal transplantation;Klinicheskaia khirurgiia;2022-12-30
4. Steroid‐free maintenance immunosuppression using alemtuzumab in pediatric kidney transplantation: Long‐term longitudinal follow‐up;Pediatric Transplantation;2021-10-23
5. Considerations and controversies of pharmacologic management of the pediatric kidney transplant recipient;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3